These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 32978904)

  • 1. Diagnostic significance and carcinogenic mechanism of pan-cancer gene POU5F1 in liver hepatocellular carcinoma.
    He D; Zhang X; Tu J
    Cancer Med; 2020 Dec; 9(23):8782-8800. PubMed ID: 32978904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of potential crucial genes associated with the pathogenesis and prognosis of liver hepatocellular carcinoma.
    Shi L; Shang X; Nie K; Lin Z; Zheng M; Wang M; Yuan H; Zhu Z
    J Clin Pathol; 2021 Aug; 74(8):504-512. PubMed ID: 33004423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Construction of liver hepatocellular carcinoma-specific lncRNA-miRNA-mRNA network based on bioinformatics analysis.
    Wang R; Hu X; Liu X; Bai L; Gu J; Li Q
    PLoS One; 2021; 16(4):e0249881. PubMed ID: 33861762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carcinogenesis effects of E2F transcription factor 8 (E2F8) in hepatocellular carcinoma outcomes: an integrated bioinformatic report.
    Lü Y; Zhang J; Li L; Li S; Yang Z
    Biosci Rep; 2020 Feb; 40(2):. PubMed ID: 31990034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Pyroptosis-Related Gene Signature to Predict Patients' Prognosis and Immune Landscape in Liver Hepatocellular Carcinoma.
    Wang J; Huang Z; Lu H; Zhang R; Feng Q; He A
    Comput Math Methods Med; 2022; 2022():1258480. PubMed ID: 35242200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pan-cancer analysis identifies
    Chang QH; Mao T; Tao Y; Dong T; Tang XX; Ge GH; Xu ZJ
    Aging (Albany NY); 2021 Mar; 13(8):11096-11119. PubMed ID: 33744857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DDR1 is a Novel Biomarker and Potential Therapeutic Target for the Combination Treatment of Liver Hepatocellular Carcinoma.
    Li T; Hu H; Song Y; Shi Y; Hu D; Shen W; Ning B
    Cancer Control; 2024; 31():10732748241286257. PubMed ID: 39284684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycolysis-related gene expression profiling serves as a novel prognosis risk predictor for human hepatocellular carcinoma.
    Zhang L; Li Y; Dai Y; Wang D; Wang X; Cao Y; Liu W; Tao Z
    Sci Rep; 2021 Sep; 11(1):18875. PubMed ID: 34556750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrated Single-cell and Transcriptome Sequencing Analyses Identified PREX1 as an Immune-related Prognostic Biomarker for Liver Hepatocellular Carcinoma.
    Yang J; Fan LY; Shi KY
    Int J Med Sci; 2024; 21(8):1559-1574. PubMed ID: 38903921
    [No Abstract]   [Full Text] [Related]  

  • 10. Bioinformatics analysis identifies DYNC1I1 as prognosis marker in male patients with liver hepatocellular carcinoma.
    Zhou J; Zhu Y; Ma S; Li Y; Liu K; Xu S; Li X; Li L; Hu J; Liu Y
    PLoS One; 2021; 16(10):e0258797. PubMed ID: 34679093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrated Bioinformatics and Experimental Analysis Identified TRIM28 a Potential Prognostic Biomarker and Correlated with Immune Infiltrates in Liver Hepatocellular Carcinoma.
    Han J; Wang Y; Zhou H; Ai S; Wan D
    Comput Math Methods Med; 2022; 2022():6267851. PubMed ID: 36238495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation analysis of RDM1 gene with immune infiltration and clinical prognosis of hepatocellular carcinoma.
    Qiu C; Li Z; Cao W; Cai X; Ye L; Zhang C; Ma Y; Wang X; Yang Y
    Biosci Rep; 2021 Sep; 41(9):. PubMed ID: 34435618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploring the role of CDCA4 in liver hepatocellular carcinoma using bioinformatics analysis and experiments.
    Liang C; Long K; Zheng W; Zhong R; Li Z; Zhu S; Gu S; Zhu C; Yang Y
    Medicine (Baltimore); 2024 May; 103(18):e38028. PubMed ID: 38701314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Placental-Cadherin, a biomarker for local immune status and poor prognosis among patients with tongue squamous cell carcinoma.
    Wang H; Yu T; Mao L
    Eur Arch Otorhinolaryngol; 2022 Jul; 279(7):3597-3609. PubMed ID: 34825969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of the implication of steroid 5 alpha-reductase 3 on prognosis and immune microenvironment in Liver Hepatocellular Carcinoma.
    Lu Y; Liu Z; Zheng Y; Liu X; Liu X; Chen N; Mao K; Lin W
    Ann Med; 2024 Dec; 56(1):2408463. PubMed ID: 39340288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value and gene regulatory network of CMSS1 in hepatocellular carcinoma.
    Chen C; Wang C; Liu W; Chen J; Chen L; Luo X; Wu J
    Cancer Biomark; 2024; 39(4):361-370. PubMed ID: 38160346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrative transcriptome analysis identifies a crotonylation gene signature for predicting prognosis and drug sensitivity in hepatocellular carcinoma.
    Yang B; Wen F; Cui Y
    J Cell Mol Med; 2024 Oct; 28(20):e70083. PubMed ID: 39428564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of Potential Hub Genes Related to Diagnosis and Prognosis of Hepatitis B Virus-Related Hepatocellular Carcinoma via Integrated Bioinformatics Analysis.
    Tang Y; Zhang Y; Hu X
    Biomed Res Int; 2020; 2020():4251761. PubMed ID: 33376723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prognostic and antitumor roles of key genes of ferroptosis in liver hepatocellular cancer and stomach adenocarcinoma.
    Pei W; Jiang M; Liu H; Song J; Hu J
    Cancer Biomark; 2024; 39(4):335-347. PubMed ID: 38393890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NCAPG is a prognostic biomarker associated with vascular invasion in hepatocellular carcinoma.
    Guo ZY; Zhu ZT
    Eur Rev Med Pharmacol Sci; 2021 Dec; 25(23):7238-7251. PubMed ID: 34919223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.